New York State Common Retirement Fund
ABOS icon

New York State Common Retirement Fund’s Acumen Pharmaceuticals ABOS Stock Holding History

New York State Common Retirement Fund’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.7K Buy
+36,200
New +$89.4K ﹤0.01% 2711
2025
Q2 		– Sell
-9,800
Closed -$10.8K – 3198
2025
Q1 		$10.8K Hold
9,800
– – ﹤0.01% 3072
2024
Q4 		$16.9K Hold
9,800
– – ﹤0.01% 3067
2024
Q3 		$24.3K Sell
9,800
-32,600
-77% -$88.4K ﹤0.01% 3017
2024
Q2 		$103K Buy
+42,400
New +$135K ﹤0.01% 2788
2022
Q3 		– Sell
-257
Closed -$1K – 3254
2022
Q2 		$1K Sell
257
-23,724
-99% -$89.1K ﹤0.01% 3305
2022
Q1 		$94K Buy
23,981
+18,500
+338% +$101K ﹤0.01% 3032
2021
Q4 		$37K Buy
+5,481
New +$60.2K ﹤0.01% 3264

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

New York State Common Retirement Fund's ABOS Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 36,200 shares worth $96.7K. The stake represents ﹤0.01% of the portfolio and ranks #2711 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ABOS as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in ABOS in Q4 2021 and has held it in 8 quarters since. The position peaked at $103K in Q2 2024. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • New York State Common Retirement Fund held 36,200 shares of Acumen Pharmaceuticals worth $96.7K as of Q2 2026.
  • Acumen Pharmaceuticals was a new New York State Common Retirement Fund position in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2711 holding.
  • New York State Common Retirement Fund first reported a position in Acumen Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
  • New York State Common Retirement Fund's Acumen Pharmaceuticals position peaked at $103K in Q2 2024.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.